Skip to main content
HCC: Atezolizumab+bevacizumab treatment outcome unaffected by the underlying liver etiology
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
HCC: Atezolizumab+bevacizumab treatment outcome unaffected by the underlying liver etiology
User login
Username
Password
Reset your password
Concept
Lead
score
Hepatocellular Carcinoma
1
1
Liver
0
0.78
Cancer
0
0.63
Biologic Therapy
0
0.38
Angiogenesis Inhibitors
0
0.31
Humanized Monoclonal Antibody
0
0.31
Specialty
Lead
score
Hematology-Oncology
1
1
Gastroenterology
0
1
Edit Tags